Yissum Ltd.

53 articles with Yissum Ltd.

• Pepticom Raises $5 Million in Series A Funding

  10/24/2019

  Pepticom, a leader in artificial intelligence peptide drug discovery, announced today that it has secured $5 million in Series A funding from the Chartered Group.

• Yissum Hosts First-of-its-Kind Conference to Drive Academic-industry Collaboration in Cannabis Research & Development

  5/1/2019

  Yissum and Hebrew University Lead Cannabis Technology Transfer as Holders of the Most Academic Patents Worldwide

• Yissum Announces New Platform for 3D Printing of Personalized Medicine

  11/6/2018

  Technology to be presented at the 3D Printing and Beyond Conference at The Hebrew University of Jerusalem on November 7, 2018

• NewStem Announces $4 million Seed Investment

  7/16/2018

  Hebrew University Spinout Focuses on Improving Chemotherapy Success

• Hebrew University Researchers to Collaborate With GRAIL

  6/12/2018

  Strategic partnership will focus on generating methylation data as part of ongoing research for early cancer detection

• Therapix Signs Exclusive License Agreement With Yissum Ltd. For Nasal Drug Delivery Technology

  4/5/2017

• Phytecs, Leading U.S. Biotech Focused On The Endocannabinoid System, Partners With Yissum Ltd. To Discover New ECS-Targeting Compounds, Test Potential Of Fluorinated CBD

  2/22/2017

• Kamada Ltd. Announces Collaboration Agreement With Yissum Ltd. For Development Of A Recombinant Human Alpha 1 Antitrypsin

  11/15/2016

• Agrinnovation, Yissum Ltd.'s Agritech Investment Fund, Invests In Medical Cannabis Startup, Cannabi-Tech

  9/22/2016

• Therapix Signed A Binding MOU With Yissum Ltd., The Technology Transfer Company Of The Hebrew University Of Jerusalem, To Receive A License To Use A Formulation For Nasal Administration Of Cannabinoid Substances

  7/5/2016

• Yissum Ltd. To Receive $1.2 Million Of Funding From Aurum Ventures For Development Of Novel Diagnostic Platform

  5/23/2016

• Yissum Ltd. And BioTheryX Sign Licensing Agreement For The Development Of Next-Generation Protein Degradation And Immunomodulatory Treatment For Hematological Cancers

  5/4/2016

• Yissum Ltd. Forms Neteera Technologies Ltd. For Remote Sensing Of Biological Indicators

  3/15/2016

• Yissum Ltd. Announces Formation Of Agritech Investment Fund

  10/26/2015

• Yissum Ltd. Introduces A Novel Technology For Drug Screening And Testing Of Orphan Diseases Without Utilizing Animal Models

  7/27/2015

• Yissum Ltd. And ICL Expand Research Collaboration In The Area Of Advanced Materials

  6/18/2015

• PhytoTech Medical Limited (ASX:PYL) Yissum Ltd. Licensing Agreement Amendment

  5/7/2015

• ISA Scientific, Yissum Ltd., Hadasit Ltd., And The Kennedy Trust For Rheumatology Research To Collaborate On Treating Diabetes And Other Serious Health Conditions With Cannabidiol

  3/23/2015

• PhytoTech Medical Limited (ASX:PYL) Commencement Of R&D With Yissum Ltd.

  2/3/2015

• Lockheed Martin Corporation And Yissum Ltd. Sign Long Term Research Collaboration Agreement

  10/6/2014